ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Heavy Smokers And Drinkers Have Different Brain Chemistry

May 30, 2003

Senate Passes Non-Binding Resolution To Double NIH Budget Over Five Years

May 23, 1997

NIH Deputy Director Ruth Kirschstein Plans Transition To Senior Advisor

October 4, 2002

Guest Editorial By ACS Chief Medical Officer Otis Brawley: ACS Revises Process for Making Guidelines

January 13, 2012

Accelerated Approval In Oncology Shaves A Year Off Development Time, FDA Data Show

October 30, 2009

Reagan’s 1983 Budget Would Fund NCI Grants to 180 Payline, 26 Percent Of Approved; Indirect Costs Cut

March 5, 1982